Immuno-Oncology
Immunotherapy in the Age of COVID-19
BY BRIELLE BENYON
Immunotherapy-Related Pneumonitis in Lung Cancer
BY BETH SANDY, MSN, CRNP
Immunotherapy Does Not Increase Death Risk in Patients With COVID-19
BY RACHEL NAROZNIAK, MA
Expert Talks Progress, What's Next in Melanoma Treatment
BY HAYLEY VIRGIL
Upfront 4-Drug Regimen Is Tolerable in Lung Cancer Treatment
BY BRITTANY COTE
Expert Talks Immunotherapy for TNBC Treatment
BY JESSICA HERGERT
ICYMI: A Rundown of the 5 Latest FDA Approvals
BY BRIELLE BENYON
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.